Epilepsy
We recommend
Cenobamate in the Therapy of Pharmacoresistant Epilepsy in a Warfarinized Patient – A Case Study
A case study from Czech practice presents a patient with pharmacoresistant epilepsy and concurrent warfarin medication for heart valve replacement, where the INR value remained within the cardiologist’s recommended range without further adjustments to anticoagulant therapy during combined antiepileptic therapy with cenobamate (CNB) under the recommended dose titration.
No content is currently available on this topic.
E-courses on this topic
Conferences news
Go to records
Go to records
Go to records
Go to records
Go to records
Go to records
Most read on this topic
Journal on this topic
Related topic